Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · IEX Real-Time Price · USD
2.150
+0.030 (1.42%)
At close: Jul 19, 2024, 12:00 AM
2.190
+0.040 (1.86%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
$382,626
Profits / Employee
-$46,989
Market Cap
174.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 1,024 |
OrganiGram Holdings | 984 |
Metagenomi | 236 |
Puma Biotechnology | 185 |
Rigel Pharmaceuticals | 147 |
Adverum Biotechnologies | 121 |
MediWound | 100 |
Acumen Pharmaceuticals | 52 |
IPHA News
- 5 weeks ago - Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial - Business Wire
- 6 weeks ago - Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides - Business Wire
- 7 weeks ago - Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Business Wire
- 2 months ago - Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting - Business Wire
- 2 months ago - Outcome of Innate Pharma's 2024 Annual General Meeting - Business Wire
- 2 months ago - Innate Pharma: Clarification Regarding SAR443579 Designation - Business Wire
- 2 months ago - Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress - Business Wire
- 2 months ago - Innate Pharma Reports First Quarter 2024 Business Update and Financial Results - Business Wire